contemporarypediatrics3d
FDA approves concizumab-mtci prophylaxis for hemophilia A and B
The indication is for patients 12 years and older hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors. The FDA has approved concizumab-mtci (Alhemo; Novo Nordisk) in ...
contemporarypediatrics3d
FDA approves first generic GLP-1 injection for type 2 diabetes in patients 10 years and up
The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up. The US Food and Drug Administration (FDA) has ...
contemporarypediatrics6d
FDA expands setmelanotide indication to patients as young as 2 years
The expanded indication is approved to reduce excess body weight and maintain reduction long-term in children 2 years and up with obesity due to BBS, POMC, or LEPR deficiency. The FDA has approved an ...
contemporarypediatrics6d
Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial
Positive phase 3 data for inhaled insulin Afrezza Inhalation Powder (MannKind Corporation) in children and adolescents aged 4 to 17 years has been announced by MannKind Corporation. 1 According to the ...
contemporarypediatrics6d
Lawrence Eichenfield, MD, talks tapinarof cream, 1%, nemolizumab FDA approvals for atopic dermatitis
"Tapinarof comes in with that mixture of the short-term studies and longer-term studies intermittently, giving us a nice, effective alternative non-steroid for eczema across the ages." Lawrence ...
contemporarypediatrics7d
Understanding pediatric ED readiness: Quartiles, disparities, and cost
Nathan Kuppermann, MD, MPH, explains the different quartiles of the pediatric emergency department readiness scale, and why the top tier is so crucial for pediatric patients. Nathan Kuppermann, MD, ...
contemporarypediatrics7d
Healthy prenatal diet could be upstream obesity prevention strategy
"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ...
contemporarypediatrics8d
FDA approves remestemcel-L-rknd to treat steroid-refractory acute graft-versus-host disease
Ahead of the January 7, 2025 prescription drug user act fee date, the FDA has granted approval to Mesoblast's remestemcel-L-rknd (Ryoncil) for the treatment of steroid-refractory acute ...
contemporarypediatrics8d
COVID-19 Roundtable: Considering off label therapies
This week, our experts weigh in on treatments not specifically indicated for COVID-19 treatment, including metformin, and concerns around using medications in this way. During the earliest stages of ...
contemporarypediatrics8d
Contemporary Pediatrics’ top 3 FDA approvals of 2024
From new topical dermatology treatments for atopic dermatitis to the first nasal spray to treat type 1 allergic reactions, these are our top FDA approvals of 2024. Each year, the FDA approves several ...
contemporarypediatrics6d
Screen use and ways to protect pediatric eyesight
The article by Colleen Sloan, PA-C, RDN, Healthy eyes in a digital world, provides detailed information about the relationship between nutrition and screen time for young children. Sloan presents the ...
contemporarypediatrics8d
2-week-old girl with lesions on her lips, cheeks, and nasolabial folds
Can you diagnose this healthy, 8.2-lb girl with lesions primarily on her lower lip but also her upper lip, cheeks, and nasolabial folds? A healthy, 8.2-lb girl aged 2 weeks presented with lesions ...